<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little work has been performed to determine roles of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ATP-sensitive <z:chebi fb="120" ids="26216">potassium</z:chebi> channels (mitoK(ATP)) in ischemic preconditioning (<z:chebi fb="76" ids="53004">IPC</z:chebi>) in brain </plain></SENT>
<SENT sid="1" pm="."><plain>To investigate the role on cerebral <z:chebi fb="76" ids="53004">IPC</z:chebi>, we examined effect of 5-hydroxydecanoate (5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), a selective mitoK(ATP) blocker, and <z:chebi fb="0" ids="4495">diazoxide</z:chebi> (DZX), a selective mitoK(ATP) opener on various <z:chebi fb="76" ids="53004">IPC</z:chebi> models </plain></SENT>
<SENT sid="2" pm="."><plain>An <z:chebi fb="76" ids="53004">IPC</z:chebi> model with gerbil: 2 min bilateral common carotid <z:mp ids='MP_0006134'>arteries occlusion</z:mp> (BLCO)+24 h recovery+5 min BLCO </plain></SENT>
<SENT sid="3" pm="."><plain>5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, DZX, vehicle was administered 30 min before 5 min BLCO </plain></SENT>
<SENT sid="4" pm="."><plain>Seven days later, surviving CA1 neurons were counted </plain></SENT>
<SENT sid="5" pm="."><plain>A focal <z:chebi fb="76" ids="53004">IPC</z:chebi> model with rat: 15 min middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO)+48 h recovery+90 min MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty-four hours before 90 min MCAO, 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>, DZX, or vehicle was administered </plain></SENT>
<SENT sid="7" pm="."><plain>One day after 90 min MCAO, neurological symptoms and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were evaluated </plain></SENT>
<SENT sid="8" pm="."><plain>An in vitro <z:chebi fb="76" ids="53004">IPC</z:chebi> model with primary neuronal cultures: 8 min oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD)+24 h recovery+70 min OGD </plain></SENT>
<SENT sid="9" pm="."><plain>Thirty minutes before 70 min OGD, 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> or DZX were added </plain></SENT>
<SENT sid="10" pm="."><plain>One day later, surviving neurons were counted </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> membrane potential was also monitored </plain></SENT>
<SENT sid="12" pm="."><plain>5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> significantly attenuated the protective effect of <z:chebi fb="76" ids="53004">IPC</z:chebi> in gerbil model, rat model, and in vitro OGD model </plain></SENT>
<SENT sid="13" pm="."><plain>DZX significantly facilitated the protective effect of <z:chebi fb="76" ids="53004">IPC</z:chebi> in gerbil and rat model </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membranes were depolarized with <z:chebi fb="76" ids="53004">IPC</z:chebi>, and 5-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> treatment significantly reduced this effect </plain></SENT>
<SENT sid="15" pm="."><plain>These results strongly suggest that mitoK(ATP) channel activation plays a key role in development of a protective mechanism of cerebral <z:chebi fb="76" ids="53004">IPC</z:chebi> </plain></SENT>
</text></document>